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A  sensitive  analytical  method  using  mixed  mode  HPLC  separation  coupled  with  charged  aerosol  detection
(CAD)  was  developed  for quantitative  analysis  of  lithium.  The  method  is  capable  of separating  lithium
ion  from  different  drug  matrices  and other  ions  in a single  run  thus  eliminating  the  organic  matrix  and
ionic  analyte  interferences  without  extensive  sample  preparation  such  as  derivatization  and  extraction.
The  separation  space  and  chromatographic  conditions  are  deﬁned  by systematic  studies  of  the reten-
tion  behaviors  of lithium  and  potential  interfering  ions  and  different  type  of  pharmaceutical  APIs (activeithium
ixed-mode chromatography
AD detection
race analysis
harmaceutics
pharmaceutical  ingredients)  under  reversed-phase,  HILIC  and  cation/anion  exchange  mechanisms.  Com-
pared to other  current  analytical  techniques  for  lithium  analysis,  the  presented  method  provides  a  new
approach  and  demonstrates  high  sensitivity  (0.02  ng  for LOD  and  0.08  ng for  LOQ  in both  standard  and
sample  solution).  The  method  has  been  validated  for pharmaceutical  samples  and  can be  potentially
applied  to  biological,  food  and  environmental  samples.
©  2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/4.0/).. Introduction
Lithium is an alkali metal and exists mainly as lithium salts
n nature. Lithium and its compounds have wide industrial appli-
ations, including but not limited to pharmaceutical, material,
utomobile and batteries. Lithium carbonate is used as a pre-
cription drug for treating mania and bipolar disorders. It has a
arrow therapeutic index and the blood concentration of lithium
s required to remain in a tight range of 2.8–8.3 mg/L [1–3]. Higher
evel could pose serious and even lethal toxicity to the patients,
hile lower levels do not provide adequate efﬁcacy. It is very
mportant to accurately quantitate blood lithium concentration to
nsure drug efﬁcacy and patients safety.
Lithium may  occur in pharmaceutical products as a residual
mpurity due to lithium containing reagents often used in the pro-
ess for drug synthesis. For example, lithium salt is a commonly
sed catalyst for pericyclic reactions [4] and asymmetric additions
5,6]. Organolithium compounds are reactive nucleophile reagents
hat are widely used for Li/H exchange and nucleophilic addition
eactions to other carbon electrophiles [7]. The USP Ad Hoc Advi-
ory Panel has proposed a limit of 6 g/g for lithium in oral and
∗ Corresponding author. Tel.: +1 650 467 8470.
E-mail address: zhang.kelly@gene.com (K. Zhang).
ttp://dx.doi.org/10.1016/j.chroma.2015.06.063
021-9673/© 2015 The Authors. Published by Elsevier B.V. This is an open access article uparenteral materials [8], and ICH Q3D proposed a limit of 78 g/g,
39 g/g and 2.5 g/g for lithium respectively in oral, parenteral and
inhaled drugs [9]. Thus, it is critical to sensitively quantify trace
amounts of lithium in pharmaceutical products to ensure patient
safety.
Currently, there are various analytical techniques for lithium
analysis including ﬂame-AES [10,11], ﬂame-AAS [12], ICP-AES
[3,13], ICP-MS [14,15], spectroﬂuometry [16,17], ﬂow through
optode [18] and potentiometry with ion selective electrodes [19].
ICP spectroscopy is widely used for elemental analysis. The sensi-
tivity for lithium is ideally at 100 ppb [3] by ICP-AES and 0.05 ppb
[15] by ICP-MS. However, ICP spectroscopy methods are subject
to matrix and spectral interferences for lithium analysis [10,20].
Spectral interference are caused by inter-elemental spectra over-
lapping, especially from sodium and potassium [12,15,21], and
other elements or molecules such as calcium, magnesium, chlo-
ride, glucose, phosphate and ethanol [15,22,23]. The matrices of
various drugs have been found to interfere with lithium analysis as
well [10]. While sodium and potassium can strongly enhance the
signal for lithium [12,21] chloride depresses the signal [23]. Spec-
tral interference may  be overcome by adding similar concentration
of the interfering elements to the standard solution. However if
the amount of interfering elements is not known in the samples,
the approach is invalid. In ICP-MS, lithium ionization is affected by
sodium, calcium and potassium which cause inaccurate analysis
result [20].
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
8 atogr. 
e
s
s
m
m
i
b
s
t
D
m
n
e
t
a
a
e
e
d
i
f
a
f
f
c
c
s
s
e
s
c
T
r
e
o
u
s
b
s
p
T
e
f
b
a
m
c
a
i
i
t
b
g
h
s
s
f
p
p
o
c
The Acclaim Trinity P1 column is constructed of silica base modiﬁed
with negatively charged polymer surface and positively charged8 L. Dai et al. / J. Chrom
Ion-selective electrode (ISE) method is fast and sensitive,
specially for clinical samples. However, ionic interference and
electivity is a major limitation. Additionally, the effect of ionic
trength of sample solution and potential drift during a sequence
easurement are frequently present. There have been efforts
ade to use aromatic organic reagents, crown ether and amide
onophores to achieve high lithium selectivity over sodium for
lood lithium analysis [24]. For pharmaceutical analysis, method
peed and sensitivity as well as method selectivity, robustness,
ransferability and the automation capability are very important.
ue to the large amount of samples, it is desired to have auto-
ated sample analysis for pharmaceutics with unattended and
on-interrupt sequence automation. Therefore, ISE is not consid-
red a suitable method here for pharmaceutical samples whereas
he methods are expected to be used in a regulated environment
nd transferred to different manufacturing and QC sites for large
mount of samples.
Extraction of lithium from the matrix could help to reduce or
liminate the matrix effect and improves the analysis result. How-
ver, extensive sample preparations including complete sample
igestion and solid–liquid extraction are needed. Often extraction
s not pragmatic and sample recovery is problematic, particularly
or trace level analysis.
Ion chromatography has been used for trace amount lithium
nalysis [22,25,26]. In ion chromatography, lithium is separated
rom sodium and potassium thus eliminating the elemental inter-
erence as encountered in spectroscopic techniques. However, ion
hromatography requires aqueous mobile phase for separation and
annot tolerate the injection of large amount of drug with low
olubility. Additionally, ion chromatography requires a special LC
ystem and the detection is typically limited to conductivity and
lectrochemical detectors.
HILIC has been used for analysis of polar and charged analytes
uch as proteins and ions [27,28]. In HILIC mode, it is generally
onsidered that water layer forms on the polar stationary phase.
he polar analyte partitions into this water absorbed layer and gets
etained, the less polar analyte has less penetration to the layer thus
lutes earlier with the non-polar organic mobile phase. Since high
rganic mobile phase is needed to retain the polar compounds, by
sing HILIC retention mechanism alone is not enough for complex
amples that contain components with distinct polarity, hydropho-
icity and charge status.
The pharmaceutical API matrix includes acidic, basic and neutral
mall molecule compounds that have different physico-chemical
roperties and vary widely in retention time by chromatography.
he interfering cations (Na+, K+) and anions (Cl−, PO43−) frequently
xist in drug matrix. Due to the wide range of chemical properties
rom these potential interfering components, it is almost impossi-
le to separate each analyte using a single stationary phase with
 single retention mechanism. Often it requires different chro-
atography conditions for the assay due to variation of the matrix
ompounds which create repeated works in method development
nd validations. Mixed mode stationary phases that had character-
stics of anion exchange chromatography (AEX) and hydrophobic
nteraction chromatography (HIC) were initially reported for pro-
ein separation [29]. In recent years, mixed mode columns have
ecome a popular tool that is complimentary to conventional sin-
le phase columns. Mixed-mode HPLC coupled with CAD detection
as proven to be an excellent approach for ion analysis [30]. In this
tudy, we explored developing a mixed-mode analysis method to
eparate lithium cation from the major interfering ions and dif-
erent matrices. The purpose is to build a sensitive and accurate
latform method for lithium analysis for pharmaceutical products
ossessing different physicochemical properties, and eliminate
rganic matrix and inorganic ion interferences without sample pre-
oncentration or derivatization.A 1408 (2015) 87–92
2. Experimental
2.1. Reagents and materials
All chemicals were ACS grade or better unless otherwise indi-
cated. Lithium hydroxide monohydrate was from BP Biomedicals
(Solon, OH, USA). Sodium chloride, potassium phosphate and
sodium naproxene were from Sigma–Aldrich (St. Louis, MO,  USA).
Tamoxifene was from MP  Biomedicals (Solon, OH, USA). Drug com-
pounds GB1, GB2, GN1 were synthesized at Genentech.
HPLC grade acetonitrile was  from Burdick & Jackson (Morris-
town, NJ, USA) and ammonium formate from Sigma–Aldrich (St.
Louis, MO,  USA). De-ionized water (>18.2 MO)  was  from Milli-Q
water puriﬁcation system (Millipore, Bedford, MA,  USA).
Ion free polypropylene HPLC vial with septa and cap (PN 079812)
were from Thermo Fisher Scientiﬁc (Sunnyvale, CA, USA).
2.2. Instrumentation
The chromatographic system included an Agilent HP-1200
series high performance liquid chromatography (Agilent Tech-
nologies, Santa Clara, CA) equipped with an on-line degasser,
quarternary pump, autosampler, column thermostat, diode array
UV detector and a Corona Plus CAD detector (Thermo Fisher Sci-
entiﬁc, Chelmsford, MA). ChemStation software version B.04.01
(Agilent Technologies, Santa Clara, CA) was  used for data acqui-
sition and processing.
Column used is Thermo Fisher Scientiﬁc’s Acclaim Trinity P1
(3.0 mm × 50 mm,  3 m,  PN 071388).
2.3. Chromatographic conditions
For a ternary mixed phase separation, three mobile phase com-
ponents were used: 50 mM or 100 mM ammonium formate buffer
(pH 4.0), de-ionized water and acetonitrile. Gradient elution was
used for separation of lithium from the interfering ions and drug
matrix. The ﬂow rate was  0.5 mL/min. The injection volume was
10 L. CAD detection operated under a nitrogen pressure of 35 psi.
In the subsequent chromatographic calculation, void time (t0)
was determined by the elution time of an unretained solvent
peak. The retention factor k′ was calculated using the formula:
k′ = (tR − t0)/t0, where tR is the retention time of analyte peak. Limit
of detection (LOD) is based on peak signal/noise ≥3 and Limit of
Quantitation (LOQ) ≥10.
2.4. Standard and sample preparation
All standard and samples were prepared in diluent acetoni-
trile/water (1/1, v/v) and class A glass volumetric ﬂask with
sonication and vortex to facilitate dissolution. The solutions were
transferred to ion free polypropylene HPLC vials for analysis.
3. Results and discussion
Separation of ions and small molecule drugs was tested using
reversed-phase (C18, C4) and HILIC stationary phases. However,
separation of all components using a single stationary phase was
not possible with these columns. A mixed mode separation mecha-
nism was  investigated for a solution. Various mixed mode columns
were evaluated for ion separation including Primesep AB, ZIC-
pHILIC, Obelisc N and Acclaim Trinity P1. Among them, Acclaim
Trinity P1 column showed superior selectivity in ion separation.inner-pore with covalently bonded organic layer. The silica surface
provides HILIC and strong cation exchange interaction, the inner
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ore provides reversed phase and weak anion exchange interac-
ion [27]. This combination of RP/CEX/AEX would likely be efﬁcient
or the purpose of the study. Using HILIC mechanism, the more
ydrophobic drug matrix could be eluted early or in the void, and
ithium and the interfering ions could be retained longer then sep-
rated by ion exchange mechanism. In order to achieve the desired
eparation, we studied the HILIC/hydrophobic and ion exchange
nteractions on the retention of Li+, Na+, K+, Cl− and PO43− ions and
he matrix API compounds. Based on the behaviors of the ions and
atrices, we developed a platform method for lithium analysis that
liminates the elemental and matrix interference.
.1. HILIC/ion exchange characteristics in lithium/cation/anion
eparation
The retention factor k′ of Li+, Na+, K+ and Cl− vs. acetonitrile lev-
ls were studied under ionic or HILIC conditions using ﬁxed 5 mM
mmonium formate (pH 4.0) in 10–95% of acetonitrile (Fig. 1). As
hown in Fig. 1, the k′ values of the cations lithium, sodium and
otassium showed steady and modest increase with increasing ace-
onitrile but rose rapidly when acetonitrile increased to 80–90%.
nce acetonitrile reached 95%, the k’ values increased rapidly for
ll three cations.
Increasing organic content reduced the ionic strength of the
obile phase, thus causing longer retention of the cations. The dra-
atic increase of k’ values indicated that at very high organic mode
80–95% of acetonitrile), the dominant interaction shifted from
onic to HILIC. Among the cations studied, lithium is the strongest
n terms of polarizing ability followed by sodium then potassium
ased on their charge/radius ratio. HILIC interaction was  strongest
or lithium resulting in the steepest slope followed by sodium and
hen potassium.
It is noted that chloride anion showed a partially recipro-
al retention trend compared with the cations (Fig. 1). When
obile phase contained less than 50% acetonitrile, chloride did not
lute indicating strong anion exchange interaction. As acetonitrile
ncreased from 50% to 90%, the retention time of chloride steadily
ecreased and behaved differently than the cations. Since higher
cetonitrile resulted in weaker mobile phase ionic strength, Cl−
nion was expected to be retained longer. However, with higher
rganic content, the weak anion exchange domain on the column
lso became less ionized that would weaken the AEX interaction
hus anion retention. In this case, the effect from AEX weakening
xceeded that of ionic strength weakening of the mobile phase and
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ig. 1. Correlation of the retention factor k′ of ions vs. mobile phase acetonitrile
trength. Mobile phase: 5 mM ammonium formate (pH 4.0) in 10–95% acetonitrile.
efer to Section 2.3 for other chromatographic conditions.A 1408 (2015) 87–92 89
resulted in a decrease of Cl− retention. On the other hand, ion-
ization of the strong cation exchange domain was less affected
by acetonitrile change, so the cation elution was still mainly con-
trolled by ionic strength of the mobile phase. As seen in Fig. 1,
when acetonitrile increased to 95%, the retention trend of chlo-
ride reversed dramatically and behaved similarly as cations with
its k′ value increased from 13 to 16. The study demonstrated that
the dominant retention mechanism may  change in mixed mode
column due to organic/ionic variation of the mobile phase. HILIC
became the dominant interaction when mobile phase contained
large percentage of organic phase and at this level, ion exchange
became less effective for both cation and anion.
3.2. HILIC/hydrophobic interactions in API matrix separation
Pharmaceutical compounds typically have certain hydrophilic-
ity and hydrophobicity in order to be bioavailable as well as bind to
the target. We  studied three proprietary small molecule drugs and
two commercial drugs, naproxen sodium and tamoxifen as they
represented the typical pharmaceutical compounds with a range
of chemical properties. GB1, GB2 and tamoxifen are basic drugs,
GN1 is a neutral drug, naproxen is an acidic drug. Using similar
conditions described in 3.1, the hydrophilic/hydrophobic behav-
iors of these compounds were tested. As shown in Fig. 2, GB1,
GB2, naproxen and tamoxifen all have “U” shaped elution pattern
demonstrating coexistence of both hydrophobic and HILIC inter-
actions as acetonitrile level changed from low to high. At lower
acetonitrile level, the mobile phase was  more polar and the com-
pounds were retained by hydrophobic interaction. A valley bottom
was seen around 80% of acetonitrile where the compounds were
retained in minimum. As acetonitrile increased from 80% to 95%,
the retention time turned upward for all compounds except for the
neutral compound GN1 indicating that HILIC interaction became
active. At 95% acetonitrile, the k′ values for all four basic and acid
compounds increased by ∼2 folds (k′ = 1.5–3.5) suggesting that
HILIC became dominant retention mechanism. However, compared
with the cations and anions, HILIC effect was relatively limited on
the retention of API’s.
Fig. 2 shows that the neutral compound GN1 was strongly
retained by hydrophobic interaction (k′ = 9.3) at 20% acetonitrile.
As acetonitrile increased, the retention time drastically decreased
and the compound became unretained (k′ < 1) between 40% and
95% of acetonitrile. This indicates that HILIC has little effect even at
high organic level and the lack of HILIC interaction was likely due
to the compound’s neutral nature.
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Fig. 2. Correlation of retention factor k′ of API compounds vs. acetonitrile strength.
Mobile phase: 5 mM ammonium formate (pH 4.0) in 20–95% acetonitrile. Refer to
Section 2.3 for other chromatographic conditions.
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Table 1
Chromatographic condition for lithium analysis.
Column Trinity P1, 3.0 mm × 50 mm,  3 m
Flow 0.5 mL/min
Column temperature 25 ◦C
Autosampler temperature Ambient
Injection volume 10 L
Mobile phase A 50 mM ammonium formate, pH 4.0
Mobile phase B Acetonitrile
Mobile phase C Deionized water
Gradient Time % A % B % C
0 10 75 15
6 10 50 40
6.1 90 5 5
10 90 5 5
10.1 10 75 15
15 10 75 15
min0 5 10
pA
0
10
20
30
40
50
60
70
Li+
Na
+
K
+
Cl
-
PO4
3
-
GB1
Fig. 5. Chromatogram for the separation of lithium, GB1 drug matrix and otherition. Mobile phase: 95% acetonitrile and 5% ammonium formate (pH 4.0) at 40 mM,
0  mM and 100 mM.  Refer to Section 2.3 for other chromatographic conditions.
.3. Retention behavior with ionic strength and pH under HILIC
ode
The correlation between retention of cations and anions vs.
ifferent buffer strengths or pH under HILIC mode was studied.
sing isocratic mobile phase containing 95% of acetonitrile with
% ammonium formate either with ionic concentration range of
0–100 mM (pH = 4.0) or pH range of 3.5–4.5 (50 mM).
Fig. 3 shows that the retention factor k′ of all cations and anions
ere strongly affected by the ionic strength of the mobile phase.
lthough HILIC was the dominant interaction at high organic level
s shown in Fig. 1, ion exchange simultaneously existed. With
igher ionic concentration (100 mM),  retention due to HILIC was
educed for all the ions. The API’s were not affected by ionic
trength and conﬁrmed that they were not involved in ion exchange
ctivities.
Fig. 4 shows that pH had little effect on retention of all API com-
ounds and very small effect on the retention of ions. Since HILIC
as the dominant interaction at 95% of acetonitrile, this indicates
hat HILIC retention force is not signiﬁcantly affected by pH.
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k' vs. pH
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Potass ium
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GB1
GB2
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ig. 4. Correlation of retention factor k′ vs. buffer pH. Mobile phase: 95% acetonitrile
nd 5% ammonium formate (50 mM)  at pH 3.5, 4.0 and 4.5. Refer to Section 2.3 for
ther chromatographic conditions.potential ions. with Li 16.1 g/mL, Na 33.8 g/mL, K 52.4 g/mL, Cl 52.1 g/mL and
PO4 138.9 g/mL. See Table 1 for chromatographic conditions.
3.4. Chromatographic separation space and conditions of lithium
analysis
The studies showed a clear separation space where drug matrix,
anions and other cations are separated from lithium. Fig. 1 shows
that the separation between lithium and other ions occurred in
the range of 70–80% acetonitrile. Fig. 2 shows that between 70%
and 90% acetonitrile levels, all drug compounds were little or only
slightly retained. These revealed that the separation space around
75% acetonitrile gives the best selectivity of lithium among all other
cations and compound matrices. For anions Cl− and PO43−, a gradi-
ent mobile phase with stronger ionic strength was applied to elute
them out.
The ﬁnal chromatographic condition is listed in Table 1. Fig. 5
shows the chromatogram of the separation of the Li+, Na+, K+, Cl−
and PO43− along with API GB1.
Since the API properties may  vary, it is possible to ﬁne tune the
organic level or ionic gradient to achieve optimal separation of the
matrix and interfering ions from lithium. However, it is not recom-
mended to operate at very high organic level as HILIC interaction
has strong effect which could cause the ions being retained too
strongly and not elute out.
3.5. Method validationThe ﬁnal method (Table 1) was  validated for linearity, sensitivity
(LOD, LOQ), accuracy, speciﬁcity and precision.
L. Dai et al. / J. Chromatogr. A 1408 (2015) 87–92 91
Table  2
Result of method accuracy and precision.
Concentration (g/mL) % recovery (n = 6) % RSD
0.016 (LOQ) 103 7.5
0.032 96 3.2
0.33  97 2.2
1.61  97 1.1
min0 5
pA
0
20
40
60
80
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Drug GN 1
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Table 4
Lithium quantitation limit results.
Injection
volume
10 L 20 L 50 L 100 L
Standard
Solution
0.16 ng (16 ppb) 0.16 ng (16 ppb) 0.08 ng (8 ppb) 0.08 ng (8 ppb)
Sample
solution
in  drug
GN1
0.16 ng (16 ppb) 0.16 ng (16 ppb) 0.08 ng (8 ppb) 0.08 ng (8 ppb)ig. 6. Chromatogram of lithium accuracy validation in drug matrix GN1. Concen-
ration of Li+ is 1.6 g/mL.
.5.1. Linearity and range
Linearity of the method was evaluated by analyzing the standard
olutions in a serial dilution of the stock standard. The CAD area
esponse (y) of lithium vs. concentration (x) is linear in the range
f 0.0168–1.681 g/mL with y = 81.878x + 1.7071 and R2 = 0.9992.
.5.2. Accuracy and precision
Accuracy was tested at LOQ and three higher concentration lev-
ls by spiking the lithium standards into six replicates of GN1. The
esult is shown in Table 2 with the recovery ranging between 96%
nd 103% for all levels and %RSD between 1.1% and 3.2% for the
ange of 0.032–1.61 g/mL and <10% at LOQ level. Fig. 6 shows the
hromatogram of an accuracy sample.
.5.3. Sensitivity
The sensitivity of lithium was tested in the standard solution
ithout sample matrix and spiked into sample matrix. The sam-
le solution was prepared by spiking the lithium standard into
rug substance GN1. The results for the LOD and LOQ are listed
n Tables 3 and 4. The LOD was determined to be 0.08 ng (8 ppb)
n both standard and sample solutions with 10 L injection vol-
me. As the injection volume was increased to 20 L and 50 L or
00 L, LOD further improved respectively to 0.04 ng (4 ppb) and
.02 ng (2 ppb). The LOQ was determined to be 0.16 ng (16 ppb) in
oth standard and sample solutions with injection volume of 10
r 20 L. When the injection volume increased to 50 L or 100 L,
he LOQ could be achieved at 0.08 ng (8 ppb). However it was  noted
hat as the injection volume increased, the peak sometimes became
able 3
ithium detection limit results.
Injection
volume
10 L 20 L 50 L 100 L
Standard
solution
0.08 ng (8 ppb) 0.04 ng (4 ppb) 0.02 ng (2 ppb) 0.02 ng (2 ppb)
Sample
solution
in  drug
GN1
sample
matrix
0.08 ng (8 ppb) 0.04 ng (4 ppb) 0.02 ng (2 ppb) 0.02 ng (2 ppb)sample
matrix
broader or split. Therefore it was not always desirable to increase
the injection volume in order to achieve better LOQ. The detec-
tion and quantitation sensitivity were similar in both standard
and sample solutions conﬁrming that there were no interference
from the matrix. Comparing with the sensitivity by ICP-AES, this
method yielded comparable LOD and LOQ for lithium analysis with
the advantages of no pre-sample treatment and elemental/matrix
interferences. Lithium ion was found to have exceptionally high
detection sensitivity by CAD relative to sodium ion which has been
reported as having the lowest LOD of 0.5 ng [30]. The 25-fold sen-
sitivity difference is probably due to the fact that lithium has least
weight and largest charge/radius ratio among all metal ions.
3.5.4. Speciﬁcity
The method is speciﬁc for lithium analysis since the elemental
and matrix interference were separated by the chromatography.
Recovery of lithium in both standard and sample solutions demon-
strated excellent accuracy.
4. Conclusion
A universal method for lithium analysis was developed using
mixed mode hydrophobic/ion exchange mechanisms in reversed
phase mobile phase. A CAD detector was  used for the detection and
quantitation of lithium ion. The multimodal mechanisms allowed
separation of lithium from the interfering matrix compound and
other ions, therefore provided outstanding selectivity and accu-
racy results. Compared with the ICP-AES spectrometry technique,
the method presented excellent sensitivity for the determination
of lithium ion with similar levels for LOD and LOQ. Another advan-
tage of the method is the minimum sample treatment required
which provides high efﬁciency throughput. The method may  not
be the fastest method for lithium analysis for a single run, but it
can be automated for large amount of samples in a sequence. The
study demonstrates that using mixed mode HPLC chromatography
is a simple and sensitive approach to eliminate interferences from
coexisting ions and matrix. The method has been validated for phar-
maceutical samples and can potentially be expanded for lithium
analysis in biological, environmental and food samples.
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